Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01090141 · ClinicalTrials.gov registry record · Phase 4
Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers
A Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT01090141: Completed Phase 4 study, sponsored by University of Texas Southwestern Medical Center.
NCT01090141 is a Phase 4 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 36 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01090141, a Phase 4 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the drug concentration of Micafungin amongst healthy volunteers having different weight groups.
Interventions
- DRUG Micafungin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2009-11 |
| Est. Completion | 2010-06 |
| Phase | Phase 4 |
What the finished NCT01090141 record still lists
NCT01090141 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 36 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 1 intervention - of which Micafungin is the first listed.
NCT01090141 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01090141 about?
NCT01090141 is a clinical study titled "Drug Concentration Analysis of Micafungin in Overweight, Obese, and Extremely Obese Volunteers". The purpose of this study is to assess the drug concentration of Micafungin amongst healthy volunteers having different weight groups.
What is the current status of trial NCT01090141?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2009-11. Estimated completion is 2010-06.
What interventions are being tested in trial NCT01090141?
The interventions under investigation include: Micafungin (DRUG).
Who is sponsoring clinical trial NCT01090141?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01090141's enrollment target sits among peer trials
36 1490th of 2000 higher than 495 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00929006 · 36 participants · Early Phase 1
Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism
- NCT01891318 · 36 participants · Phase 1
Neoadjuvant Radiosurgery for Resectable Brain Metastases: Phase I/II Study
- NCT02291848 · 36 participants · Phase 1
Tumor-Associated Antigen-Specific Cytotoxic T-Lymphocytes for Multiple Myeloma
- NCT02366819 · 36 participants · Phase 4
Genetic Analysis-Guided Irinotecan Hydrochloride Dosing of mFOLFIRINOX in Treating Patients With Locally Advanced Gastroesophageal or Stomach Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia